OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ALNY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALNY is expected to report earnings to fall 30.75% to 22 cents per share on October 23

Alnylam Pharmaceuticals ALNY Stock Earnings Reports

Q3'25

Est.

$0.22

Q2'25

Beat

by $0.91

Q1'25

Beat

by $0.92

Q4'24

Beat

by $0.64

Q3'24

Beat

by $0.43

The last earnings report on July 31 showed earnings per share of 31 cents, beating the estimate of -58 cents. With 1.51M shares outstanding, the current market capitalization sits at 56.35B.

View a ticker or compare two or three

Compare

ALNY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALNY
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALNY showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

675 West Kendall Street

Phone

+1 617 551-8200

Employees

2100

Web

https://www.alnylam.com